Tuesday, 29 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 32 announcements

Share price
₹206.59
Market cap
₹27,504 Cr
Revenue (annual)
₹8,869 Cr
Net profit (annual)
₹-325.9 Cr
P/E (TTM)
-87.7×Sector 49.7×
Promoter holding
34.80%-0.06% QoQ
FII holding
12.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:44 IST NSE
Management Change

Piramal Pharma Management Change

Piramal Pharma Limited announced a leadership overhaul, appointing Maneesh Sharma as Company Secretary and Compliance Officer, effective April 29, 2026. The board also approved the re-appointment of Nandini Piramal and Peter DeYoung as Executive Directors, alongside Independent Directors Sridhar Gorthi and Peter Stevenson. These changes ensure long-term governance stability and executive continuity.

Execution
36-60 months